000 02598 a2200673 4500
005 20250516185329.0
264 0 _c20140922
008 201409s 0 0 eng d
022 _a1879-0720
024 7 _a10.1016/j.ejps.2013.12.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Hsiao-yin
245 0 0 _aCell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells.
_h[electronic resource]
260 _bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_cMar 2014
300 _a35-44 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAggrecans
_xgenetics
650 0 4 _aCartilage, Articular
_xcytology
650 0 4 _aCell Cycle
650 0 4 _aCell Survival
650 0 4 _aCells, Cultured
650 0 4 _aChitosan
_xchemistry
650 0 4 _aChondrocytes
_xmetabolism
650 0 4 _aCollagen Type I
_xgenetics
650 0 4 _aCollagen Type I, alpha 1 Chain
650 0 4 _aCollagen Type II
_xgenetics
650 0 4 _aCore Binding Factor Alpha 1 Subunit
_xgenetics
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
_xgenetics
650 0 4 _aCyclooxygenase 2
_xgenetics
650 0 4 _aGene Expression
650 0 4 _aGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)
_xgenetics
650 0 4 _aHumans
650 0 4 _aHyaluronic Acid
_xchemistry
650 0 4 _aInflammation
650 0 4 _aIntervertebral Disc
_xcytology
650 0 4 _aKnee Joint
650 0 4 _aLipids
_xchemistry
650 0 4 _aLumbar Vertebrae
650 0 4 _aMesenchymal Stem Cells
_xmetabolism
650 0 4 _aOsteopontin
_xgenetics
650 0 4 _aPolyethyleneimine
_xchemistry
650 0 4 _aProliferating Cell Nuclear Antigen
_xgenetics
650 0 4 _aRNA Interference
650 0 4 _aRNA, Small Interfering
_xadministration & dosage
650 0 4 _aTransfection
700 1 _aVonk, Lucienne A
700 1 _aLicht, Ruud
700 1 _avan Boxtel, Antonetta M G
700 1 _aBekkers, Joris E J
700 1 _aKragten, Angela H M
700 1 _aHein, San
700 1 _aVarghese, Oommen P
700 1 _aHoward, Kenneth A
700 1 _aÖner, F Cumhur
700 1 _aDhert, Wouter J A
700 1 _aCreemers, Laura B
773 0 _tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_gvol. 53
_gp. 35-44
856 4 0 _uhttps://doi.org/10.1016/j.ejps.2013.12.006
_zAvailable from publisher's website
999 _c23374518
_d23374518